BeStock  
Stocks › Biotechnology › TSHA

Taysha Gene Therapies TSHA

US equityMarket cap rank #3032Biotechnology
$3.72 −$0.05 (-1.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.71 -0.27%
Open$3.67
Prev close$3.77
Day range$3.60 – $3.80
Volume3.15M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

TSHA Stock News

Headlines matching Taysha Gene Therapies or the TSHA ticker, most recent first.

  • Wolfe Research Initiates Taysha Gene Therapies(TSHA.US) With Buy RatingMarket news · 17 Sep 2026 · Direct mention
  • BofA Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy RatingMarket news · 14 Aug 2026 · Direct mention
  • CCORF Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $17Market news · 12 Aug 2026 · Direct mention
  • Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $12Market news · 12 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $19Market news · 12 Aug 2026 · Direct mention
  • Piper Sandler Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $12Market news · 12 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $13Market news · 12 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $13 PositiveMarket news · 22 Jul 2026 · Direct mention
  • BMO Capital Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $14Market news · 1 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Taysha Gene Therapies(TSHA.US), With a Forecast Between $12 to $15Market news · 1 Jul 2026 · Direct mention
  • Piper Sandler Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $12 PositiveMarket news · 30 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)TipRanks · 30 Jun 2026 · Direct mention
  • Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $15 PositiveMarket news · 30 Jun 2026 · Direct mention
  • BMO Capital Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $14 PositiveMarket news · 23 Jun 2026 · Direct mention
  • BofA Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $10 PositiveMarket news · 23 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TSHA.

Sign in to join the discussion.

Scroll to Top